Smith Darren Charlton 3 Filing

From the Filing

EDGAR Filing Documents for 0001628280-26-022571 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 3 - Initial statement of beneficial ownership of securities: SEC Accession No. 0001628280-26-022571 Filing Date 2026-04-01 Accepted 2026-04-01 07:25:06 Documents 4 Period of Report 2026-03-18 Document Format Files Seq Description Document Type Size 1 FORM 3 wk-form3_1775042700.html 3 1 FORM 3 wk-form3_1775042700.xml 3 8889 2 EX-24 poa-darrensmith.htm EX-24 5512 3 GRAPHIC poa-darrensmith001.jpg GRAPHIC 238743 4 poa-darrensmith002.jpg GRAPHIC 96117 Complete submission text file 0001628280-26-022571.txt 477229 Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855 Telix Pharmaceuticals Ltd ( Issuer ) CIK : 0002007191 (see all company filings) EIN. : 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 55 FLEMINGTON ROAD, LEVEL 4 NORTH MELBOURNE VICTORIA Australia 3051 Business Address Smith Darren Charlton ( Reporting ) CIK : 0002122447 (see all company filings) Type: 3 | Act: 34 | File No.: 001-42128 | Film No.: 26824690